North Ohio Heart CenterM
Cardiology
Dr. Charles O'Shaughnessy, MD
|
|
Give Review
Charles O'Shaughnessy is an expert in the field of Cardiology. He studied medicine at University of Toledo College of Medicine. He received awards:"Fellow (FACC)". Doctor Charles O'Shaughnessy, MD is also published. He has 41 publications published. The lastest publication: "A random graph model for the final-size distribution of household infections.'
Publications
- A provisional strategy for treating true bifurcation lesions employing a scoring balloon for the side branch: Final Results of the AGILITY Trial.
- A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in Coronary arte...
- Long-term benefit of the TAXUS Liberté stent in small vessels and long lesions. - TASIUS ATLAS program-.
- A prospective, randomized evaluation of a novel everolimus-eluting Coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-E...
- 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortoCoronary saphenous vein grafts the randomized BARRICADE (barrier app...
- Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials.
- Safety and efficacy of renal Artery stenting following suboptimal renal angioplasty for de novo and restenotic ostial lesions: results from a nonrandomized, prospectiv...
- A randomized comparison of the ENDEAVOR zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native Coronary lesions 12-month outcomes from t...
- Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease U...
- Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo Coronary lesions: 2-year...
- Frequency and clinical consequences associated with sidebranch occlusion during stent implantation using zotarolimus-eluting and paclitaxel-eluting Coronary stents.
- Intravenous platelet blockade with cangrelor during PCI.
- Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with corona...
- Comparison of the CardioShield filter with the guardwire balloon in the prevention of embolisation during vein graft intervention: results from the CAPTIVE randomised ...
- TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.
- Reduced risk of restenosis in small vessels and reduced risk of Myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from ...
- Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
- A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel Coronary disease: primary results of the COSTAR (Cobalt Chromium Ste...
- Polymer-based, paclitaxel-eluting TAXUS Liberté stent in de novo lesions: the pivotal TAXUS ATLAS trial.
- Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native Coronary artery disease: a randomized controlled trial.
- Comparison of the efficacy of direct Coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIR...
- Impact of routine angiographic follow-up on the clinical benefits of paclitaxel-eluting stents: results from the TAXUS-IV trial.
- Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
- Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization.
- Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex Coronary artery disease: a randomized controlled trial.
- Relationship between angiographic late loss and target lesion revascularization after Coronary stent implantation: analysis from the TAXUS-IV trial.
- Statin therapy, LDL cholesterol, C-reactive protein, and Coronary artery disease.
- Non-polymer-based paclitaxel-coated Coronary stents for the treatment of patients with de novo Coronary lesions: angiographic follow-up of the DELIVER clinical trial.
- One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial.
- A polymer-based, paclitaxel-eluting stent in patients with Coronary artery disease.
- Sirolimus-eluting stents versus standard stents in patients with stenosis in a native Coronary artery.
- The StarClose Vascular Closure System: interventional results from the CLIP study.
- Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial.
- Procedural and late outcomes following MULTI-LINK DUET Coronary stent deployment.
- Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials).
- Comparison of PRE-dilatation vs direct stenting in Coronary treatment using the Medtronic AVE S670 Coronary Stent System (the PREDICT trial).
- Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native Coronary arteries.
- The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native Coronary arterial lesions.
- Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of Coronary stenoses.
- A random graph model for the final-size distribution of household infections.
Schools
University of Toledo College of Medicine
Akron City Hospital
University Hosps Cleveland
Procedures Preformed
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
University of Toledo College of Medicine
Drug Facts
| NPI NUMBER | 1831178003 | |
| NPPES Provider LastName | O'SHAUGHNESSY | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 440356400 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 8956.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831178003 |
| Last Name Of The Provider | O'SHAUGHNESSY |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
Dr. Danny Blankenship, MD |
|
|
Dr. Sean V. Lyons, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kara Quan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ismail S. Ahmed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahul Dhingra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Osama Ibrahim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Steele, MD |
|
Dr. Naim Farhat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Razak U. Kherani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Vacante, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wassim Eid, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel J. Puccinelli Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Danny C. Blankenshhip, MD
This Doctor is OpenDoctor Recommended.
|